Pharming Group NV (PHAR)
12.60
-0.02
(-0.16%)
USD |
NASDAQ |
May 19, 16:00
12.60
0.00 (0.00%)
After-Hours: 16:26
Pharming Group Total Assets (Quarterly) : 489.36M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| uniQure NV | 778.71M |
| ProQR Therapeutics NV | 114.11M |
| argenx SE | -- |
| NewAmsterdam Pharma Co. NV | 732.64M |
| CervoMed, Inc. | 15.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 220.41M |
| Shareholders Equity (Quarterly) | 268.96M |
| Debt to Equity Ratio | 0.4321 |
| Current Ratio | 2.630 |
| Net Debt Paydown Yield | -0.07% |